|
1
|
Burkett EL and Hershberger RE: Clinical
and genetic issues in familial dilated cardiomyopathy. J Am Coll
Cardiol. 45:969–981. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jefferies JL and Towbin JA: Dilated
cardiomyopathy. Lancet. 375:752–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Felker GM, Thompson RE, Hare JM, Hruban
RH, Clemetson DE, Howard DL, Baughman KL and Kasper EK: Underlying
causes and long-term survival in patients with initially
unexplained cardiomyopathy. N Engl J Med. 342:1077–1084. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Isner JM, Kearney M, Bortman S and Passeri
J: Apoptosis in human atherosclerosis and restenosis. Circulation.
91:2703–2711. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weber KT, Brilla CG and Janicki JS:
Myocardial fibrosis: Functional significance and regulatory
factors. Cardiovasc Res. 27:341–348. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Frangogiannis NG, Smith CW and Entman ML:
The inflammatory response in myocardial infarction. Cardiovasc Res.
53:31–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Agocha A, Lee HW and Eghbali-Webb M:
Hypoxia regulates basal and induced DNA synthesis and collagen type
I production in human cardiac fibroblasts: Effects of transforming
growth factor-beta1, thyroid hormone, angiotensin II and basic
fibroblast growth factor. J Mol Cell Cardiol. 29:2233–2244. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Di Napoli P, Taccardi AA, Grilli A, Felaco
M, Balbone A, Angelucci D, Gallina S, Calafiore AM, De Caterina R
and Barsotti A: Left ventricular wall stress as a direct correlate
of cardiomyocyte apoptosis in patients with severe dilated
cardiomyopathy. Am Heart J. 146:1105–1111. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsipis A, Athanassiadou AM, Athanassiadou
P, Kavantzas N, Agrogiannis G and Patsouris E: Apoptosis-related
factors p53, bcl-2 and the defects of force transmission in dilated
cardiomyopathy. Pathol Res Pract. 206:625–630. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cleary ML and Sklar J: Nucleotide sequence
of a t(14;18) chromosomal breakpoint in follicular lymphoma and
demonstration of a breakpoint-cluster region near a
transcriptionally active locus on chromosome 18. Proc Natl Acad Sci
USA. 82:7439–7443. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sato T, Hanada M, Bodrug S, Irie S, Iwama
N, Boise LH, Thompson CB, Golemis E, Fong L and Wang HG:
Interactions among members of the Bcl-2 protein family analyzed
with a yeast two-hybrid system. Proc Natl Acad Sci USA.
91:9238–9242. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oltvai ZN and Korsmeyer SJ: Checkpoints of
dueling dimers foil death wishes. Cell. 79:189–192. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yin XM, Oltvai ZN and Korsmeyer SJ: BH1
and BH2 domains of Bcl-2 are required for inhibition of apoptosis
and heterodimerization with Bax. Nature. 369:321–323. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen SJ, Wang JL, Chen JH and Huang RN:
Possible involvement of glutathione and p53 in trichloroethylene-
and perchloroethylene-induced lipid peroxidation and apoptosis in
human lung cancer cells. Free Radic Biol Med. 33:464–472. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Latif N, Khan MA, Birks E, O'Farrell A,
Westbrook J, Dunn MJ and Yacoub MH: Upregulation of the Bcl-2
family of proteins in end stage heart failure. J Am Coll Cardiol.
35:1769–1777. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Voinnet O: RNA silencing: Small RNAs as
ubiquitous regulators of gene expression. Curr Opin Plant Biol.
5:444–451. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hammond SM: Dicing and slicing: The core
machinery of the RNA interference pathway. FEBS Lett.
579:5822–5829. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ikeda S, Kong SW, Lu J, Bisping E, Zhang
H, Allen PD, Golub TR, Pieske B and Pu WT: Altered microRNA
expression in human heart disease. Physiol Genomics. 31:367–373.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nair N, Kumar S, Gongora E and Gupta S:
Circulating miRNA as novel markers for diastolic dysfunction. Mol
Cell Biochem. 376:33–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dong S, Ma W, Hao B, Hu F, Yan L, Yan X,
Wang Y, Chen Z and Wang Z: microRNA-21 promotes cardiac fibrosis
and development of heart failure with preserved left ventricular
ejection fraction by up-regulating Bcl-2. Int J Clin Exp Pathol.
7:565–574. 2014.PubMed/NCBI
|
|
21
|
Richardson P, McKenna W, Bristow M, Maisch
B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I,
et al: Report of the 1995 world health organization/international
society and federation of cardiology task force on the definition
and classification of cardiomyopathies. Circulation. 93:841–842.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang WB, Du QJ, Li H, Sun AJ, Qiu ZH, Wu
CN, Zhao G, Gong H, Hu K, Zou YZ and Ge JB: The therapeutic effect
of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis
during the end-stage hypertension in rats. J Cell Mol Med.
16:2227–2237. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Adams KF Jr, Dunlap SH, Sueta CA, Clarke
SW, Patterson JH, Blauwet MB, Jensen LR, Tomasko L and Koch G:
Relation between gender, etiology and survival in patients with
symptomatic heart failure. J Am Coll Cardiol. 28:1781–1788. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Han Y, Peters DC, Dokhan B and Manning WJ:
Shorter difference between myocardium and blood optimal inversion
time suggests diffuse fibrosis in dilated cardiomyopathy. J Magn
Reson Imaging. 30:967–972. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Unverferth DV, Baker PB, Swift SE, Chaffee
R, Fetters JK, Uretsky BF, Thompson ME and Leier CV: Extent of
myocardial fibrosis and cellular hypertrophy in dilated
cardiomyopathy. Am J Cardiol. 57:816–820. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saraste A, Pulkki K, Kallajoki M,
Henriksen K, Parvinen M and Voipio-Pulkki LM: Apoptosis in human
acute myocardial infarction. Circulation. 95:320–323. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mallat Z, Tedgui A, Fontaliran F, Frank R,
Durigon M and Fontaine G: Evidence of apoptosis in arrhythmogenic
right ventricular dysplasia. N Engl J Med. 335:1190–1196. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Boise LH, González-García M, Postema CE,
Ding L, Lindsten T, Turka LA, Mao X, Nuñez G and Thompson CB:
bcl-x, a bcl-2-related gene that functions as a dominant regulator
of apoptotic cell death. Cell. 74:597–608. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Antonsson B, Conti F, Ciavatta A,
Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod
JJ, Mazzei G, et al: Inhibition of Bax channel-forming activity by
Bcl-2. Science. 277:370–372. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thum T, Gross C, Fiedler J, Fischer T,
Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, et
al: MicroRNA-21 contributes to myocardial disease by stimulating
MAP kinase signalling in fibroblasts. Nature. 456:980–984. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Roy S, Khanna S, Hussain SR, Biswas S,
Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ and Sen CK: MicroRNA
expression in response to murine myocardial infarction: miR-21
regulates fibroblast metalloprotease-2 via phosphatase and tensin
homologue. Cardiovasc Res. 82:21–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
van Rooij E, Sutherland LB, Liu N,
Williams AH, McAnally J, Gerard RD, Richardson JA and Olson EN: A
signature pattern of stress-responsive microRNAs that can evoke
cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA.
103:18255–18260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai
B, Wang N, Li X, Feng T, Hong Y and Yang B: Downregulation of
miR-133 and miR-590 contributes to nicotine-induced atrial
remodelling in canines. Cardiovasc Res. 83:465–472. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Engelhardt S, Hein L, Wiesmann F and Lohse
MJ: Progressive hypertrophy and heart failure in beta1-adrenergic
receptor transgenic mice. Proc Natl Acad Sci USA. 96:7059–7064.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bisognano JD, Weinberger HD, Bohlmeyer TJ,
Pende A, Raynolds MV, Sastravaha A, Roden R, Asano K, Blaxall BC,
Wu SC, et al: Myocardial-directed overexpression of the human
beta(1)-adrenergic receptor in transgenic mice. J Mol Cell Cardiol.
32:817–830. 2000. View Article : Google Scholar : PubMed/NCBI
|
